Show latest about:
Israeli stocks on Wall St
Israeli stocks in Europe
Mergers & acquisitions
Politics, foreign affairs
Start-ups & VC
Israeli stocks in NY
Israel in depth
Check-Cap files to raise $15m on Nasdaq
Check-Cap is developing a pill for making an X-ray scan of the intestine.
24 Dec 14 19:07
FDA approves Teva's GRANIX for self-administration
From early 2015 patients will themselves be able to administer the treatment for neutropenia, associated with leukemia.
23 Dec 14 15:38
Mapi Pharma again considers Nasdaq IPO
Mapi will now raise $10-30 million in the first quarter of 2015, either through an IPO or a private placement.
23 Dec 14 14:34
Medivation takes up $335m Curetech licensing option
The agreement gives Medivation the license to develop and commercialize Curetech's pidilizumab cancer treatment.
21 Dec 14 14:06
FDA approves Teva allergy spray for children
21 Dec 14 11:25
Compugen, Johns Hopkins team on immune markers
18 Dec 14 16:13
RedHill boosted by University of Minnesota deal
18 Dec 14 14:50
Teva and Russian partner at loggerheads
17 Dec 14 20:47
US court delays Teva launch of generic Celebrex
17 Dec 14 12:39
"Copaxone risk dramatically down"
16 Dec 14 18:28
BioLineRX signs Novartis strategic cooperation deal
16 Dec 14 14:56
Another Israeli cannabis co to be traded on Wall Street
15 Dec 14 18:29
Pfizer buys Israel-developed hormone drug from Opko
15 Dec 14 17:11
Pontifax first fund earns 37% return
14 Dec 14 19:09
Good-bye chemotherapy, hello immunotherapy
Compugen CEO Dr. Anat Cohen-Dayag: Today, we dare to talk about curing cancer.
27 Nov 14 11:36
Cancer treatment developer Efranat raises $4.5m
Efranat is conducting human trials of its drug, which uses controversial substance GcMAF.
18 Nov 14 16:13
5 - Consumer Physics: We let you know what you're eating
The company is developing a mobile food scanner that can quantify all food ingredients.
30 Oct 14 20:42
For more results from our archive,